Analysis of chlamydial recombination in vivo

体内衣原体重组分析

基本信息

  • 批准号:
    8035464
  • 负责人:
  • 金额:
    $ 18.09万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-03-01 至 2013-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Recent work in our and other laboratories has demonstrated the chlamydiae to be actively recombinogenic. This supports previous nucleotide sequence analysis supporting intraspecies recombination in this system. We have a long-term goal of understanding the mechanisms of genetic exchange by chlamydiae, particularly as it may occur in vivo. We also are pursuing the use of recombinant strains as tools to examine chlamydial gene function, as these organisms are not amenable to targeted gene introduction or disruption. To address these goals, we propose to explore chlamydial recombination in a mouse model of chlamydial genital infection. Our research group has identified or selected for antibiotic resistant strains of Chlamydia muridarum, C. trachomatis, and C. suis, all of which are recombinogenic in vitro. We will use these strains in experiments to accomplish the following Aims. First, we will test the hypothesis that chlamydiae can recombine in vivo by inoculating pairs of differently antibiotic resistant chlamydial strains into mice that will then be treated with antibiotics that will select for recombinants. Conditions will be optimized to recover chlamydiae that grow in these antibiotic treated mice, and their genomes will be sequenced to determine the nature of recombination in this system. The second aim of the proposal will use in vitro generated recombinants to examine gene function in host tropism by different, but highly related, chlamydial species. The murine pathogen C. muridarum will be crossed in vitro with a strain of the human pathogen C. trachomatis, and a set of independent recombinants will be cloned and characterized in vitro. The genomes will be sequences for a set of these progeny, and a subset (approx. 12) of these variable strains will be inoculated into mice. Chlamydial development will be assessed by culture and histological analysis of these infected animals. Bioinformatics analyses will then be used to associate chlamydial genotype with the phenotypes identified in vitro and in vivo. We anticipate that these studies will identify genes or gene sets that are associated with phenotypic variability between the species. PUBLIC HEALTH RELEVANCE: Infections by different chlamydial species leads to serious human diseases worldwide, including blinding trachoma, pelvic inflammatory disease, and infertility. While there is no practical genetic system yet available to study gene function and virulence properties, chlamydiae recombine actively in vitro. This is an interesting phenomenon that may be a useful tool for studying chlamydial gene function. In this proposal we will use an in vivo model to explore both the mechanisms and significance of recombination in vivo, and to explore gene function in an animal model system. These studies should help identify candidate proteins that can be targeted for novel immunogenic or therapeutic purposes, and address the question of the significance of recombination in the chlamydial system in vivo.
描述(由申请人提供):最近在我们和其他实验室的工作已经证明衣原体是积极重组的。这支持了先前的核苷酸序列分析,支持该系统中的种内重组。我们的长期目标是了解衣原体的遗传交换机制,特别是它可能发生在体内。我们也在寻求使用重组菌株作为工具来检查衣原体基因功能,因为这些生物体不适合靶向基因导入或破坏。为了实现这些目标,我们建议在衣原体生殖器感染的小鼠模型中探索衣原体重组。我们的研究小组已经鉴定或选择了耐药菌株muridarum衣原体,沙眼衣原体和猪衣原体,所有这些菌株都是体外重组的。我们将在实验中使用这些菌株来达到以下目的。首先,我们将验证衣原体可以在体内重组的假设,方法是将对不同抗生素耐药的衣原体菌株接种到小鼠体内,然后用抗生素治疗小鼠,抗生素将选择重组菌株。将优化条件以恢复在这些抗生素治疗小鼠中生长的衣原体,并对其基因组进行测序以确定该系统中重组的性质。该提案的第二个目的是利用体外生成的重组体来检测不同但高度相关的衣原体物种在宿主趋向性中的基因功能。将鼠源沙眼衣原体与人源沙眼衣原体进行体外杂交,克隆出一组独立的重组体并进行体外鉴定。基因组将是这些后代中的一组的序列,以及一个子集(大约。将这些变异菌株中的12种接种到小鼠体内。将通过对这些感染动物的培养和组织学分析来评估衣原体的发育情况。然后,生物信息学分析将用于将衣原体基因型与体外和体内鉴定的表型联系起来。我们预计这些研究将确定与物种之间表型变异相关的基因或基因集。

项目成果

期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Resistance to a novel antichlamydial compound is mediated through mutations in Chlamydia trachomatis secY.
对新型抗衣原体化合物的耐药性是通过沙眼衣原体 secY 的突变介导的。
  • DOI:
    10.1128/aac.00356-12
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    4.9
  • 作者:
    Sandoz,KelsiM;Eriksen,StevenG;Jeffrey,BrendanM;Suchland,RobertJ;Putman,TimothyE;Hruby,DennisE;Jordan,Robert;Rockey,DanielD
  • 通讯作者:
    Rockey,DanielD
Antibiotic resistance in Chlamydiae.
  • DOI:
    10.2217/fmb.10.96
  • 发表时间:
    2010-09
  • 期刊:
  • 影响因子:
    3.1
  • 作者:
    Sandoz KM;Rockey DD
  • 通讯作者:
    Rockey DD
Chlamydia spp. development is differentially altered by treatment with the LpxC inhibitor LPC-011.
  • DOI:
    10.1186/s12866-017-0992-8
  • 发表时间:
    2017-04-24
  • 期刊:
  • 影响因子:
    4.2
  • 作者:
    Cram ED;Rockey DD;Dolan BP
  • 通讯作者:
    Dolan BP
Genomic and phenotypic characterization of in vitro-generated Chlamydia trachomatis recombinants.
  • DOI:
    10.1186/1471-2180-13-142
  • 发表时间:
    2013-06-20
  • 期刊:
  • 影响因子:
    4.2
  • 作者:
    Jeffrey BM;Suchland RJ;Eriksen SG;Sandoz KM;Rockey DD
  • 通讯作者:
    Rockey DD
The broad-spectrum antiviral compound ST-669 restricts chlamydial inclusion development and bacterial growth and localizes to host cell lipid droplets within treated cells.
广谱抗病毒化合物 ST-669 限制衣原体包涵体发育和细菌生长,并定位于处理细胞内的宿主细胞脂滴。
  • DOI:
    10.1128/aac.02064-13
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    4.9
  • 作者:
    Sandoz,KelsiM;Valiant,WilliamG;Eriksen,StevenG;Hruby,DennisE;Allen3rd,RobertD;Rockey,DanielD
  • 通讯作者:
    Rockey,DanielD
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DANIEL D ROCKEY其他文献

DANIEL D ROCKEY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DANIEL D ROCKEY', 18)}}的其他基金

Remnant diagnostic samples for high resolution genotyping of Chlamydia trachomatis
用于沙眼衣原体高分辨率基因分型的残留诊断样本
  • 批准号:
    10301367
  • 财政年份:
    2020
  • 资助金额:
    $ 18.09万
  • 项目类别:
Genome-wide analysis of lateral gene transfer in Chlamydia trachomatis
沙眼衣原体横向基因转移的全基因组分析
  • 批准号:
    10057794
  • 财政年份:
    2020
  • 资助金额:
    $ 18.09万
  • 项目类别:
Genome-wide analysis of lateral gene transfer in Chlamydia trachomatis
沙眼衣原体横向基因转移的全基因组分析
  • 批准号:
    10211129
  • 财政年份:
    2020
  • 资助金额:
    $ 18.09万
  • 项目类别:
Molecular target of a novel broad-spectrum antiviral and antibacterial compound
新型广谱抗病毒和抗菌化合物的分子靶标
  • 批准号:
    9334099
  • 财政年份:
    2016
  • 资助金额:
    $ 18.09万
  • 项目类别:
Molecular target of a novel broad-spectrum antiviral and antibacterial compound
新型广谱抗病毒和抗菌化合物的分子靶标
  • 批准号:
    9093490
  • 财政年份:
    2016
  • 资助金额:
    $ 18.09万
  • 项目类别:
Analysis of chlamydial recombination in vivo
体内衣原体重组分析
  • 批准号:
    7885155
  • 财政年份:
    2010
  • 资助金额:
    $ 18.09万
  • 项目类别:
Recombination and Genetics in Chlamydia spp.
衣原体的重组和遗传学。
  • 批准号:
    7824424
  • 财政年份:
    2009
  • 资助金额:
    $ 18.09万
  • 项目类别:
Recombination and Genetics in Chlamydia spp.
衣原体的重组和遗传学。
  • 批准号:
    7936891
  • 财政年份:
    2009
  • 资助金额:
    $ 18.09万
  • 项目类别:
Genetic transformation system for Chlamydia suis
猪衣原体遗传转化系统
  • 批准号:
    7083255
  • 财政年份:
    2006
  • 资助金额:
    $ 18.09万
  • 项目类别:
Genetic transformation system for Chlamydia suis
猪衣原体遗传转化系统
  • 批准号:
    7230135
  • 财政年份:
    2006
  • 资助金额:
    $ 18.09万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 18.09万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 18.09万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 18.09万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 18.09万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 18.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 18.09万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 18.09万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 18.09万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 18.09万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 18.09万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了